Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001384028 | SCV001583391 | pathogenic | Bardet-Biedl syndrome; McKusick-Kaufman syndrome | 2020-04-09 | criteria provided, single submitter | clinical testing | Loss-of-function variants in MKKS are known to be pathogenic (PMID: 12107442, 20177705). This variant has been observed in individual(s) with Bardet-Biedl syndrome (PMID: 30718709). ClinVar contains an entry for this variant (Variation ID: 636041). This variant is present in population databases (rs776004321, ExAC 0.001%). This sequence change creates a premature translational stop signal (p.Gly280Glufs*4) in the MKKS gene. It is expected to result in an absent or disrupted protein product. For these reasons, this variant has been classified as Pathogenic. |
Prevention |
RCV004527814 | SCV004103450 | pathogenic | MKKS-related disorder | 2023-06-01 | criteria provided, single submitter | clinical testing | The MKKS c.837delA variant is predicted to result in a frameshift and premature protein termination (p.Leu279Leufs*5). This variant has been reported in the heterozygous state in an individual with Bardet-Biedl syndrome; However no additional variants were identified to explain autosomal recessive disease (Table 1, Hjortshøj et al 2010. PubMed ID: 20120035). This variant is reported in 0.0035% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/20-10393325-CT-C). Frameshift variants in MKKS are expected to be pathogenic. This variant is interpreted as pathogenic. |
Baylor Genetics | RCV003472324 | SCV004194903 | pathogenic | Bardet-Biedl syndrome 6 | 2022-12-08 | criteria provided, single submitter | clinical testing | |
Institute of Human Genetics, |
RCV004818006 | SCV005072082 | pathogenic | Retinal dystrophy | 2011-01-01 | criteria provided, single submitter | clinical testing | |
Sing |
RCV003472324 | SCV005881570 | likely pathogenic | Bardet-Biedl syndrome 6 | 2025-02-05 | criteria provided, single submitter | clinical testing | Variant is predicted to cause nonsense-mediated decay in a gene where LOF is a known cause of pathogenicity (PVS1). Homozygous allele count in gnomAD genomes or exomes are less than 0 (PM2). |
Department of Clinical Genetics, |
RCV000787621 | SCV000926605 | likely pathogenic | Bardet-Biedl syndrome | 2018-04-01 | no assertion criteria provided | research |